Monocyte receptor function in patients with rheumatoid arthritis

Area of Science:

• Immunology
• Rheumatology
• Cell Biology

Background:

• Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation.
• Monocytes play a crucial role in the immune response and inflammation.
• Fc and C3 receptors on monocytes are involved in immune complex recognition and phagocytosis.

Purpose of the Study:

• To investigate potential abnormalities in Fc and C3 receptor function of monocytes in patients with rheumatoid arthritis (RA) and osteoarthritis (OA).
• To compare monocyte receptor function between active RA patients, OA patients, and healthy volunteers.
• To assess the impact of corticosteroid treatment on monocyte Fc receptor function in RA patients.

Main Methods:

• Monocytes were isolated from patients with active RA, OA, and normal volunteers.
• Fc receptor (FcR) function was assessed by measuring E-rosette (EA) formation and EA phagocytosis.
• C3 receptor (C3R) function was evaluated by binding of EAC (complement-coated erythrocytes) and uptake of iodinated aggregated gamma globulin.

Main Results:

• Monocytes from the majority of active RA patients exhibited enhanced EA-rosette formation and EA phagocytosis compared to normal volunteers and OA patients.
• No significant differences in EAC binding or aggregated gamma globulin uptake were observed among the three groups, indicating specific FcR modulation.
• Corticosteroid-treated RA patients showed a significant depression in EA-rosette formation and phagocytosis, suggesting a modulatory effect of treatment.

Conclusions:

• Monocytes from patients with active rheumatoid arthritis display enhanced Fc receptor-mediated functions.
• These findings suggest a modulation of Fc receptor function in monocytes from RA patients.
• Corticosteroid therapy appears to suppress the enhanced Fc receptor function observed in RA monocytes.